Réduction des méfaits

Sujet

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection

Esther Truscello, Shouao Wang, Jim Young, Giada Sebastiani, Sharon L. Walmsley, Mark Hull, Curtis Cooper, Marina B. Klein J Infect Dis. 2025 Feb 4;231(1):e101-e112. doi: 10.1093/infdis/jiae487. PMID: 39417816; PMCID: PMC11793071.

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection Lire la suite »

Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences

Alunni-Menichini K, Chabot R, Guilbert-Gauthier G, Dominguez-Cancino KA, Robidoux L, L’Espérance N, Huynh C, Bertrand K, Vasilidis HM, Loslier J, de Saugy YF, Martínez P, Massamba V, Nazif-Munoz JI. Sex Reprod Healthc. 2025 Sep;45:101129. doi: 10.1016/j.srhc.2025.101129. Epub 2025 Jul 20. PMID: 40701112.

Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences Lire la suite »

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study

Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Johnson C, McCracken R. Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5. PMID: 40563109; PMCID: PMC12199528.

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study Lire la suite »

A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis

Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D. Psychiatry Res. 2025 Aug;350:116553. doi: 10.1016/j.psychres.2025.116553. Epub 2025 May 17. PMID: 40450961

A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis Lire la suite »

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing

Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D. JMIR Form Res. 2025 Jun 23;9:e71924. doi: 10.2196/71924. PMID: 40550117; PMCID: PMC12235202.

A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing Lire la suite »

A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States

Zolopa C, Clifasefi SL, Dobischok S, Gala N, Fraser-Purdy H, Phillips MK, Blackmore S, Wendt DC. Drug Alcohol Depend. 2025 Apr 1;269:112597. doi: 10.1016/j.drugalcdep.2025.112597. Epub 2025 Feb 12. PMID: 39970577.

A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States Lire la suite »

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study

Kronfli N, Mambro A, O’Brien A, Dussault C, Chalifoux S, Balso LD, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J. Int J Drug Policy. 2025 Sep;143:104873. doi: 10.1016/j.drugpo.2025.104873. Epub 2025 Jun 11. PMID: 40513132

A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study Lire la suite »